- Home
- SPNT vs CNTA Comparison
SPNT vs CNTA Comparison
Compare SPNT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNT
- CNTA
- Stock Information
- Founded
- SPNT 2011
- CNTA 2020
- Country
- SPNT Bermuda
- CNTA United Kingdom
- Employees
- SPNT N/A
- CNTA N/A
- Industry
- SPNT Property-Casualty Insurers
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- SPNT Finance
- CNTA Health Care
- Exchange
- SPNT Nasdaq
- CNTA Nasdaq
- Market Cap
- SPNT 2.3B
- CNTA 2.3B
- IPO Year
- SPNT N/A
- CNTA 2021
- Fundamental
- Price
- SPNT $15.23
- CNTA $16.46
- Analyst Decision
- SPNT
- CNTA Strong Buy
- Analyst Count
- SPNT 0
- CNTA 8
- Target Price
- SPNT N/A
- CNTA $23.71
- AVG Volume (30 Days)
- SPNT 808.0K
- CNTA 470.8K
- Earning Date
- SPNT 02-18-2025
- CNTA 11-12-2024
- Dividend Yield
- SPNT N/A
- CNTA N/A
- EPS Growth
- SPNT 31.47
- CNTA N/A
- EPS
- SPNT 1.60
- CNTA N/A
- Revenue
- SPNT $2,614,600,000.00
- CNTA $6,853,000.00
- Revenue This Year
- SPNT N/A
- CNTA N/A
- Revenue Next Year
- SPNT N/A
- CNTA N/A
- P/E Ratio
- SPNT $9.37
- CNTA N/A
- Revenue Growth
- SPNT N/A
- CNTA N/A
- 52 Week Low
- SPNT $11.27
- CNTA $7.38
- 52 Week High
- SPNT $16.50
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- SPNT 54.14
- CNTA 50.86
- Support Level
- SPNT $14.23
- CNTA $14.61
- Resistance Level
- SPNT $15.81
- CNTA $17.65
- Average True Range (ATR)
- SPNT 0.51
- CNTA 1.08
- MACD
- SPNT 0.02
- CNTA -0.10
- Stochastic Oscillator
- SPNT 50.20
- CNTA 56.74
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.